Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

2.940 +0.130 (+4.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 669,479
Open 2.910
Bid (Size) 2.820 (3)
Ask (Size) 3.130 (1)
Prev. Close 2.810
Today's Range 2.810 - 2.955
52wk Range 1.735 - 7.798
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Omeros Corporation Reports Second Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
Earnings Preview: Omeros
Via Benzinga

Performance

YTD
+18.55%
+18.55%
1 Month
-22.83%
-22.83%
3 Month
-45.56%
-45.56%
6 Month
-27.05%
-27.05%
1 Year
-12.24%
-12.24%

More News

Read More
Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
From Omeros Corporation
Via Business Wire
Omeros Announces Webcast Details for Annual Meeting of Shareholders
From Omeros Corporation
Via Business Wire
Why Shares of Omeros Dropped on Monday
Via The Motley Fool
Omeros: Q1 Earnings Insights
Via Benzinga
Earnings Preview: Omeros
Via Benzinga
Omeros's Earnings: A Preview
Via Benzinga
Why Omeros Stock Bolted Higher This Week
Via The Motley Fool
Nasdaq, Methanex And Other Big Stocks Moving Lower On Monday
Via Benzinga
Omeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association Congress
From Omeros Corporation
Via Business Wire
Omeros Corporation Announces Late-Breaking Presentation of OMS906 Data at the 2023 European Hematology Association (EHA) Congress
From Omeros Corporation
Via Business Wire
Omeros Corporation Reports First Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023
From Omeros Corporation
Via Business Wire
Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria
From Omeros Corporation
Via Business Wire
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry
Via FinancialNewsMedia
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Omeros Corporation Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program
From Omeros Corporation
Via Business Wire
Short Interest Sector Focus: Healthcare Sector
Via Benzinga
Omeros Corporation Reports Fourth Quarter and Year-End 2022 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation Confirms Absence of Financial Exposure to Silicon Valley Bank
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023
From Omeros Corporation
Via Business Wire
Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Down Over 100 Points; Tyson Foods Posts Downbeat Earnings
Via Benzinga
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.